BMI, ethnicity, HbA1c, and blood glucose are interconnected factors that shape how type 2 diabetes risk is assessed and diagnosed across the UK's diverse population. Standard BMI thresholds were developed largely from White European data and do not accurately reflect metabolic risk in people of South Asian, Chinese, or Black African and Caribbean descent, who carry greater cardiometabolic risk at lower BMI values. NICE guidance recommends adjusted BMI action thresholds for these groups, alongside HbA1c and blood glucose testing to identify prediabetes and diabetes earlier. Understanding how these markers interact — and how ethnicity influences their interpretation — is essential for equitable, effective diabetes prevention.

How Ethnicity Affects BMI Thresholds and Diabetes Risk in the UK

NICE PH46 recommends lower BMI action thresholds of 23 kg/m² and 27.5 kg/m² for South Asian, Chinese, and Black African or Caribbean adults, as these groups carry greater visceral fat and insulin resistance risk at lower BMI values than White European populations.

Body mass index (BMI) is a widely used screening tool that estimates body fat based on height and weight. However, research has consistently shown that standard BMI thresholds — developed largely from data on White European populations — do not accurately reflect metabolic risk across all ethnic groups. In particular, people from South Asian and Chinese backgrounds tend to carry a higher proportion of visceral (abdominal) fat at lower BMI values, which is more strongly associated with insulin resistance and type 2 diabetes. Evidence for people of Black African and Black Caribbean descent also suggests elevated cardiometabolic risk at lower BMI values, though the evidence base is less consistent across this group and should be interpreted with appropriate clinical judgement.

NICE public health guidance (PH46: BMI: preventing ill health and premature death in black, Asian and other minority ethnic groups) recommends using lower BMI action thresholds for people of South Asian, Chinese, and Black African or Caribbean descent when assessing type 2 diabetes risk. Specifically, NICE PH46 recommends:

• A BMI of 23 kg/m² as the threshold to offer lifestyle advice (equivalent to the 'overweight' action point used at 25 kg/m² in White European populations)

• A BMI of 27.5 kg/m² as the threshold to consider further intervention (equivalent to the 30 kg/m² obesity action point)

These are action thresholds for risk assessment and preventive intervention — they do not redefine obesity per se, but indicate the BMI levels at which earlier clinical action is warranted in higher-risk groups.

BMI alone has recognised limitations as a measure of metabolic risk. NICE obesity guidance also recommends considering waist circumference and waist-to-height ratio (a ratio below 0.5 is generally considered lower risk) alongside BMI, as these measures better reflect central adiposity and cardiometabolic risk, particularly in people from South Asian backgrounds.

Understanding these differences is an important step towards more equitable and effective diabetes prevention across the UK's diverse population.

Understanding HbA1c and Blood Glucose as Diagnostic Markers

HbA1c reflects average blood glucose over two to three months and does not require fasting, while fasting plasma glucose and OGTT measure glucose at a specific point in time; all diagnostic tests must use laboratory venous samples, not point-of-care devices.

Two primary laboratory tests are used in the UK to screen for and diagnose type 2 diabetes and prediabetes: HbA1c (glycated haemoglobin) and blood glucose measurements. Each provides distinct but complementary information about how the body is managing blood sugar.

HbA1c reflects average blood glucose levels over the preceding two to three months. It measures the proportion of haemoglobin molecules that have glucose attached to them. Because it captures a longer-term picture, it is less susceptible to short-term fluctuations caused by recent meals or stress, making it a reliable and convenient diagnostic tool. It does not require fasting.

Blood glucose tests measure glucose concentration at a specific point in time. The most commonly used formats are:

• Fasting plasma glucose (FPG): taken after at least eight hours without food or drink (other than water)

• Random plasma glucose: taken at any time, typically when symptoms of diabetes are present; a result of 11.1 mmol/L or above with symptoms is diagnostic of diabetes

• Oral glucose tolerance test (OGTT): involves a fasting glucose measurement followed by a glucose drink and a two-hour post-load reading; this is the NICE-recommended test for diagnosing gestational diabetes (per NICE NG3) and for assessing impaired glucose tolerance

Important: all diagnostic tests must be performed using laboratory venous plasma samples analysed by quality-assured methods. Point-of-care devices and home blood glucose meters must not be used to make a diagnosis of diabetes.

Both HbA1c and blood glucose tests have recognised limitations. HbA1c-based diagnosis is not appropriate in the following situations (per NICE NG28 and WHO guidance):

• Pregnancy (including suspected gestational diabetes — contact your midwife or antenatal team)

• Children and young people

• Suspected type 1 diabetes or rapidly progressive symptoms

• Recent onset of symptoms (within weeks)

• Haemoglobin variants (such as sickle cell trait or thalassaemia) — more prevalent in certain ethnic minority groups

• Haemolytic anaemia, iron deficiency anaemia, or other conditions affecting red cell turnover

• Chronic kidney disease managed with erythropoietin (EPO)

• Recent blood transfusion

In these circumstances, blood glucose testing (FPG or OGTT) is preferred. Clinicians should always interpret results in the context of the individual's clinical history and ethnicity.

NICE and NHS Guidance on Adjusted Screening Criteria by Ethnicity

NICE NG28 defines an HbA1c of 48 mmol/mol or above as diagnostic of type 2 diabetes, and 42–47 mmol/mol as non-diabetic hyperglycaemia; ethnicity-adjusted BMI thresholds trigger earlier testing and referral but NDH must be confirmed biochemically before NHS DPP referral.

NICE public health guidance (PH46) and NICE obesity guidance recommend lower BMI action thresholds for people of South Asian, Chinese, and Black African or Caribbean descent, as described above. These adjusted thresholds are intended to trigger earlier case-finding and more timely investigation with HbA1c or blood glucose testing, as well as earlier referral to weight management services where appropriate.

The NHS Health Check programme, offered to adults aged 40–74 in England, incorporates ethnicity-adjusted criteria to help identify individuals at higher risk sooner.

For diagnostic purposes, NICE guidance (NG28) specifies:

• An HbA1c of 48 mmol/mol (6.5%) or above is diagnostic of type 2 diabetes — confirmed on two separate occasions in asymptomatic individuals, or once if symptoms are present

• An HbA1c of 42–47 mmol/mol (6.0–6.4%) indicates non-diabetic hyperglycaemia (NDH) (sometimes referred to as prediabetes), warranting lifestyle intervention and annual monitoring

The NHS Diabetes Prevention Programme (NHS DPP) targets individuals with confirmed non-diabetic hyperglycaemia. Referral eligibility is primarily based on biochemical criteria: an HbA1c of 42–47 mmol/mol, or a fasting plasma glucose of 5.5–6.9 mmol/L (per OHID/NHS England service specifications). Ethnicity-adjusted BMI thresholds inform earlier testing and case-finding — and guide referral to weight management services — but NDH must be confirmed biochemically before NHS DPP referral.

The NHS DPP offers a nine-month structured behaviour change programme, available as group-based or digital formats. It is free to eligible individuals across England. If you live in Scotland, Wales, or Northern Ireland, contact your local NHS board or GP practice for information about equivalent prevention programmes available in your area.

Interpreting Your Results: What HbA1c and Blood Glucose Levels Mean

An HbA1c of 42–47 mmol/mol or fasting plasma glucose of 6.1–6.9 mmol/L indicates elevated diabetes risk requiring lifestyle intervention; in asymptomatic individuals, a raised result must be confirmed on a second laboratory test before a diagnosis is made.

Understanding what your test results mean can help you take informed steps to protect your health. The following reference ranges are used in UK clinical practice (NICE NG28; WHO diagnostic criteria):

HbA1c:

• Below 42 mmol/mol (6.0%): Normal — low risk of diabetes

• 42–47 mmol/mol (6.0–6.4%): Non-diabetic hyperglycaemia — increased risk; lifestyle changes recommended

• 48 mmol/mol (6.5%) or above: Diagnostic of type 2 diabetes (confirmed on a second laboratory test if asymptomatic)

Fasting plasma glucose:

• Below 6.1 mmol/L: Normal

• 6.1–6.9 mmol/L: Impaired fasting glucose — indicates elevated risk

• 7.0 mmol/L or above: Diagnostic of diabetes (confirmed on repeat laboratory testing if asymptomatic)

Two-hour OGTT glucose:

• Below 7.8 mmol/L: Normal glucose tolerance

• 7.8–11.0 mmol/L: Impaired glucose tolerance

• 11.1 mmol/L or above: Diagnostic of diabetes

Random plasma glucose:

• 11.1 mmol/L or above in the presence of symptoms of diabetes is diagnostic

Important notes on confirmation: In asymptomatic individuals, a single borderline or raised result does not automatically confirm a diagnosis. NICE recommends that the same test is repeated on a second occasion using a laboratory venous sample before a definitive diagnosis is made. Results should always be interpreted alongside clinical context, including symptoms, family history, ethnicity, and BMI. Diagnosis must not be based on point-of-care devices or home blood glucose meters.

If your result falls in the non-diabetic hyperglycaemia range, this is not a diagnosis of diabetes — but it is a meaningful signal that your risk is elevated and that action now can significantly reduce the likelihood of progression.

When to Seek Further Assessment and What to Expect

Adults from South Asian, Chinese, Black African, or Black Caribbean backgrounds aged 25 or over with a BMI above 23 kg/m² should contact their GP for assessment; urgent same-day care is needed if symptoms suggest diabetic ketoacidosis or hyperosmolar hyperglycaemic state.

Knowing when to seek medical advice is an important aspect of diabetes prevention and early detection.

Contact your GP practice if you experience any of the following:

• Increased thirst or frequent urination, particularly at night

• Unexplained fatigue or blurred vision

• Slow-healing wounds or recurrent infections

• Unintentional weight loss

• A family history of type 2 diabetes, particularly in a first-degree relative

• You are from a South Asian, Chinese, Black African, or Black Caribbean background and are aged 25 or over with a BMI above 23 kg/m²

Seek urgent or same-day medical assessment if you or someone you are with develops any of the following, as these may indicate a serious acute complication such as diabetic ketoacidosis (DKA) or hyperosmolar hyperglycaemic state (HHS):

• Severe or persistent vomiting, abdominal pain, or dehydration

• Drowsiness, confusion, or difficulty staying awake

• Rapid or laboured breathing

• Ketonuria (ketones in the urine) or a very high blood glucose reading

• Rapidly worsening symptoms over days to weeks (which may suggest type 1 diabetes rather than type 2)

In these situations, do not wait for a routine appointment — call 999 or go to your nearest emergency department.

If you are pregnant and have concerns about blood glucose or diabetes risk, contact your midwife or antenatal team promptly. Gestational diabetes is assessed using a specific pathway (OGTT, per NICE NG3) and is managed through antenatal services — not the standard type 2 diabetes pathway.

At a routine GP appointment, the clinician will typically take a detailed history and may arrange a laboratory blood test for HbA1c or fasting glucose. If your result falls in the non-diabetic hyperglycaemia range, your GP should offer a referral to the NHS Diabetes Prevention Programme (in England) or an equivalent local programme. If diabetes is confirmed, your GP will initiate a structured management plan in line with NICE NG28, which may include lifestyle advice, monitoring, and consideration of medication. You will also be referred for baseline assessments including blood pressure, cholesterol, kidney function (eGFR and urine albumin-to-creatinine ratio), and retinal screening.

Early identification of elevated blood glucose — even before a formal diabetes diagnosis — offers a genuine opportunity to reduce or significantly slow disease progression through targeted lifestyle changes.

Reducing Your Risk: Lifestyle and Clinical Support Available on the NHS

The free NHS Diabetes Prevention Programme offers a nine-month structured lifestyle intervention — including dietary modification, physical activity, and behaviour change support — shown to significantly reduce progression from prediabetes to type 2 diabetes; metformin may be considered where lifestyle measures are insufficient, per NICE PH38.

Type 2 diabetes is largely preventable, and even modest lifestyle changes can produce clinically meaningful reductions in risk. The landmark US Diabetes Prevention Program randomised controlled trial (Knowler et al., NEJM 2002) demonstrated that structured lifestyle intervention reduced progression from prediabetes to type 2 diabetes by approximately 58% — an effect greater than that seen with metformin alone in many groups. Evaluation data from the NHS Diabetes Prevention Programme have also demonstrated meaningful reductions in weight and HbA1c in participants completing the programme.

The NHS Diabetes Prevention Programme (NHS DPP) offers eligible individuals a free, nine-month group-based or digital programme focusing on:

• Dietary modification: reducing refined carbohydrates and added sugars, increasing fibre intake, and adopting a balanced, sustainable eating pattern

• Physical activity: aiming for at least 150 minutes of moderate-intensity activity per week, in line with UK Chief Medical Officers' guidelines

• Weight management: even a 5–10% reduction in body weight can significantly improve insulin sensitivity and lower HbA1c

• Behaviour change support: goal-setting, self-monitoring, and strategies to maintain long-term habits

For individuals from South Asian backgrounds, culturally adapted versions of the NHS DPP are available in some areas, incorporating culturally relevant dietary advice and language support. This is particularly important given that traditional South Asian diets may be higher in refined carbohydrates, and generic dietary advice may not always be directly applicable.

Beyond the NHS DPP, your GP can refer you to local weight management services and community exercise programmes. Smoking is also an independent risk factor for type 2 diabetes and insulin resistance; your GP practice or local NHS Stop Smoking Service can provide support to quit.

Pharmacological intervention with metformin may be considered in certain individuals with non-diabetic hyperglycaemia where lifestyle measures have been ineffective or are not possible, in line with NICE guidance (PH38). NICE PH38 recommends considering metformin particularly in people with a BMI of 35 kg/m² or above (or the lower ethnicity-adjusted equivalent), or those with other high-risk features such as a rapidly rising HbA1c or a history of gestational diabetes. This decision should be made in discussion with your GP, who can assess your individual circumstances and explain the potential benefits and limitations.

Speak to your GP or practice nurse to explore the full range of support available to you.

Frequently Asked Questions